Global /United States /Healthcare /Drug Manufacturers - General /JNJ
chevron_leftBack
Johnson & Johnson logo

Johnson & Johnson

JNJ
NYSE: JNJ Delayed
227.35USD -0.2%
As of 9 July 2026, Johnson & Johnson has a market cap of $547.28B USD, ranking #23 globally and #18 in the United States. It ranks #2 in the Healthcare sector, and #2 in the Drug Manufacturers - General industry.
Global Rank
23
1d: 0
1w: 0
1m: -
Country Rank
18
1d: 0
1w: 0
1m: -
Sector Rank
2
1d: 0
1w: 0
1m: -
Industry Rank
2
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$547.28BUSD
Enterprise Value
$581.23BUSD
Revenue (TTM)
$96.36BUSD
EBITDA (TTM)
$34.33BUSD
Net Income (TTM)
$21.04BUSD
EBITDA Margin
36%
Profit Margin
22%
PE Ratio
26.4
Forward PE
19.3
PS Ratio
5.7
PB Ratio
6.8
EV/EBITDA
16.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato open_in_new
Employees
138,200
Founded
1886
IPO
24 Sep 1944
Website
jnj.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.2% 0.6% -5.4% -0.2% 22% 46%

News

Loading...

JNJ Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
JNJ
ISIN: US4781601046
Shares Out.:
2.407B1 Shares Float: 2.404B2
TV:
SA:
YF:
JNJ
GF:
NQ:
JNJ
BA:
JNJ
MS:
227.35 USD
London Stock Exchange
MIC: XLON
0R34
ISIN: US4781601046
TV:
SA:
YF:
GF:
BA:
MS:
227.11 USD
Santiago Stock Exchange
MIC: XSGO
JNJ
ISIN: US4781601046
TV:
SA:
YF:
GF:
BA:
JNJ
MS:
217.47 USD
Show all 16 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Similar Companies

Industry: Drug Manufacturers - General (United States)
Name
Market Cap diff.
PE
LLY
$761.68B
39%
38.1
ABBV
$360.63B
-34%
97.4
MRK
$274.03B
-50%
15.1
PFE
$149.38B
-73%
19.5
$117.58B
-79%
16.8
$107.66B
-80%
28.1
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
$317.28B
256.25B CHF
-42%
19.9
AZN
$288.1B
215.59B GBP
-47%
27.6
NOVN
$271.03B
218.9B CHF
-50%
20.5
NOVO-B
$179.6B
1.18T DKK
-67%
11.5
SAN
$108.78B
95.26B EUR
-80%
19.9
GSK
$108.19B
80.96B GBP
-80%
14.6
chevron_leftBack